Michael Carrier
@profmikecarrier
Professor at Rutgers Law School specializing in antitrust and IP law. @[email protected]
ID:1275989323
http://camlaw.rutgers.edu/directory/mcarrier/ 17-03-2013 20:53:51
5,9K Tweets
2,2K Followers
1,2K Following
I believe this is exactly what Michael Carrier and I had suggested as one of the less restrictive alternatives to the #NCAA transfer rules in our 2019 Michigan Law Review article. It's nice, in some small way, to make a difference.
papers.ssrn.com/sol3/papers.cf…
Some say pharma patent thickets not concerning b/c high tech thickets even bigger. Relying on industry characteristics & empirical evidence on continuation patents, S. Sean Tu & I explain argument wrong and pharma thickets designed to be anticompetitive. papers.ssrn.com/sol3/papers.cf…
Senator Amy Klobuchar David Dayen Future of Music Coalition Krista Brown John Breyault National Consumers League Rediscover Fire Booking Brian Hess Sports Fans Coalition The American Prospect AAI Michael Carrier Rutgers Law ⚖️ Katie Van Dyck Michael Carrier agrees. 'The company has its tentacles in each aspect of the process and they use it in combination, not for any pro-competitive efficiencies, but rather to harm rivals at every step of the process.'
Senator Amy Klobuchar David Dayen Future of Music Coalition Krista Brown John Breyault National Consumers League Rediscover Fire Booking Brian Hess Sports Fans Coalition The American Prospect AAI Michael Carrier Rutgers Law ⚖️ Katie Van Dyck Read Michael Carrier's paper here for his full breakdown: papers.ssrn.com/sol3/papers.cf…
Senator Amy Klobuchar David Dayen Future of Music Coalition Krista Brown John Breyault National Consumers League Rediscover Fire Booking Brian Hess Sports Fans Coalition The American Prospect AAI Michael Carrier Rutgers Law ⚖️ Katie Van Dyck 'Just on exclusive dealing and tying alone, under the existing case law, the court would find Live Nation-Ticketmaster to violate antitrust law,' says Michael Carrier.
This makes sense to me. It kind of goes along with what Michael Carrier and I have been suggesting for years to avoid #antitrust liability:
2024 article (forthcoming): papers.ssrn.com/sol3/papers.cf…
2019 article:
papers.ssrn.com/sol3/papers.cf…
Pleased to see this. Marc Edelman & I have raised antitrust concerns with the 45-day transfer window: papers.ssrn.com/sol3/papers.cf…
Time’s Person of Year Taylor Swift very impressive but not have own ticketing company. 2022 tour reminded us of Ticketmaster ticketing disaster. I explain why Live Nation Entertainment is a walking antitrust violation and needs to be broken up. papers.ssrn.com/sol3/papers.cf…
“These challenges could deter drug companies from listing similar patents in the Orange Book in the future. One challenge, though, is that sometimes the FDA is unclear on whether a patent should be listed.”
—@ProfMikeCarrier, antitrust, Rutgers Law ⚖️